| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72888-185-01 | 72888-185 | HUMAN PRESCRIPTION DRUG | MYCOPHENOLATE MOFETIL | MYCOPHENOLATE MOFETIL | TABLET | ORAL | 20230801 | N/A | ANDA | ANDA212087 | Advagen Pharma Limited | MYCOPHENOLATE MOFETIL | 500 mg/1 | 100 TABLET in 1 BOTTLE (72888-185-01) |
| 72888-185-05 | 72888-185 | HUMAN PRESCRIPTION DRUG | MYCOPHENOLATE MOFETIL | MYCOPHENOLATE MOFETIL | TABLET | ORAL | 20230801 | N/A | ANDA | ANDA212087 | Advagen Pharma Limited | MYCOPHENOLATE MOFETIL | 500 mg/1 | 500 TABLET in 1 BOTTLE (72888-185-05) |
| 68254-5003-1 | 68254-5003 | HUMAN PRESCRIPTION DRUG | MYCOPHENOLATE MOFETIL | MYCOPHENOLATE MOFETIL | TABLET | ORAL | 20201221 | N/A | ANDA | ANDA212087 | CONCORD BIOTECH LIMITED | MYCOPHENOLATE MOFETIL | 500 mg/1 | 30 TABLET in 1 BOTTLE (68254-5003-1) |
| 68254-5003-2 | 68254-5003 | HUMAN PRESCRIPTION DRUG | MYCOPHENOLATE MOFETIL | MYCOPHENOLATE MOFETIL | TABLET | ORAL | 20201221 | N/A | ANDA | ANDA212087 | CONCORD BIOTECH LIMITED | MYCOPHENOLATE MOFETIL | 500 mg/1 | 100 TABLET in 1 BOTTLE (68254-5003-2) |
| 68254-5003-3 | 68254-5003 | HUMAN PRESCRIPTION DRUG | MYCOPHENOLATE MOFETIL | MYCOPHENOLATE MOFETIL | TABLET | ORAL | 20201221 | N/A | ANDA | ANDA212087 | CONCORD BIOTECH LIMITED | MYCOPHENOLATE MOFETIL | 500 mg/1 | 500 TABLET in 1 BOTTLE (68254-5003-3) |